Enhance public health communication strategies to address vaccine hesitancy and misinformation.
Pandemics
Pandemics Risk
Assessment for this date
Today's pandemic risk is moderate due to rising COVID-19 levels, emerging infectious diseases, and ongoing vaccine hesitancy.
July 24, 2025
Trend
Viewing the record for July 24, 2025 within the full trend.
Risk Drivers
What is pushing the current reading.
The current pandemic risk is influenced by a combination of factors: a slight increase in COVID-19 cases in specific regions, ongoing challenges with vaccine uptake among vulnerable populations, and the emergence of new infectious diseases such as H5N1 avian flu and MERS. Despite advancements in surveillance tools and vaccine approvals, public health systems face hurdles from misinformation and mistrust, which could hinder effective responses. Additionally, the persistence of long-term health impacts from COVID-19 and the potential for new variants underscore the need for continued vigilance.
Risk Reduction Actions
Priority actions generated from the current analysis.
Increase outreach and vaccination efforts among high-risk populations, including cancer patients and children.
Accelerate the development and deployment of new vaccines and antiviral treatments for emerging infectious diseases.
Strengthen global surveillance systems to rapidly identify and respond to new outbreaks.
Implement targeted interventions in regions experiencing upticks in COVID-19 and other infectious diseases.
Sources Monitored
Visible feeds used in this category's nightly run.
Selected Articles
Supporting articles referenced in the latest score.
- New surveillance tool can predict COVID variants of concern
- US COVID levels rise a bit in West, South
- COVID-19 vaccines offer strong protection for cancer patients, but uptake remains low
- Quick takes: More H5N1 in dairy cattle, US COVID wastewater uptick, polio in Pakistan
- Saudi Arabia confirms 9 MERS cases, including hospital cluster
- Global leaders stress importance of broad-based, cooperative research to be ready for next pandemic